LifeMD Inc.

Last updated September 27, 2026

Organization details

Legal name
LifeMD Inc.
Ownership
Public
Status
Active
Headquarters country
United States
Ticker symbol
LFMD
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0000948320

Board of directors

Board connections

2 of this board's directors also sit on 3 other boards.

Network of LifeMD Inc.'s board connections Modular Medical Inc. Modular Medical Inc. OptimizeRx Corporation OptimizeRx Corporation Quantum Computing Inc. Quantum Computing Inc. Bertrand Velge Bertrand Velge William J. Febbo William J. Febbo LifeMD Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
Sep 11, 2024 Galluppi Stefan Officer (Chief Innovation Officer) Open-market purchase +3,000 $4.93 $14,790
Aug 18, 2024 Wijnker Dennis Officer (Chief Technology Officer) Grant or award +80,000 โ€” โ€”
Jul 17, 2024 Piyush Jindal Director, Consultant Grant or award +24,835 โ€” โ€”
Apr 26, 2024 Calum Archibald Macrae Director Grant or award +16,500 โ€” โ€”
Apr 4, 2024 Naveen Bhatia Director, Consultant Inheritance +500 โ€” โ€”
Mar 21, 2024 Yecies Eric Harold Officer (General Counsel & CCO) Grant or award +56,250 โ€” โ€”
Mar 21, 2024 STAN MARIA E. Officer (Principal Accounting Officer) Grant or award +20,000 โ€” โ€”
Mar 21, 2024 Galluppi Stefan Officer (Chief Innovation Officer) Grant or award +30,000 โ€” โ€”
Mar 21, 2024 Benathen Marc David Officer (Chief Financial Officer) Grant or award +75,000 โ€” โ€”
Mar 21, 2024 Alvarez Nicholas P Officer (Chief Acquisition Officer) Grant or award +75,000 โ€” โ€”
Mar 13, 2024 Naveen Bhatia Director, Consultant Inheritance +750 โ€” โ€”
Nov 13, 2023 Schreiber Justin Officer (Chief Executive Officer) Grant or award +50,000 โ€” โ€”
Nov 6, 2023 Piyush Jindal Director Option exercise +37,500 $2.52 $94,500
Aug 31, 2023 Bertrand Velge Director Open-market purchase +60,000 $3.93 $235,800
Aug 30, 2023 Bertrand Velge Director Open-market purchase +40,000 $3.76 $150,400

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.